Associated Papers
Cyclized Peptide Inhibitors of the Small G Protein Cdc42 Mimic Binding of Effector Proteins.
Murphy NP et al.
Biochemistry, 2026
Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation.
Zhang L et al.
Journal of Clinical Immunology, 2022
Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects.
Hsu AP et al.
Blood, 2019
A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency.
Lougaris V et al.
The Journal of Allergy and Clinical Immunology, 2019
The proto-oncogene KRAS and BRAF profiles and some clinical characteristics in colorectal cancer in the Turkish population.
Ozen F et al.
Genetic Testing and Molecular Biomarkers, 2013
Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping.
Arcila M et al.
The Journal of Molecular Diagnostics : Jmd, 2011
Fluoride complexes of oncogenic Ras mutants to study the Ras-RasGap interaction.
Gremer L et al.
Biological Chemistry, 2008
The novel ankyrin-repeat containing kinase ARCK-1 acts as a suppressor of the Spalten signaling pathway during Dictyostelium development.
Aubry L et al.
Developmental Biology, 2003
Ras superfamily monomeric G proteins in carcinoma cell motility.
Oxford G et al.
Cancer Letters, 2003
Biochemical and biological characterization of a human Rac2 GTPase mutant associated with phagocytic immunodeficiency.
Gu Y et al.
The Journal of Biological Chemistry, 2001
Mutant Rac1B expression in Dictyostelium: effects on morphology, growth, endocytosis, development, and the actin cytoskeleton.
Palmieri SJ et al.
Cell Motility and the Cytoskeleton, 2000
Select a paper to view details